Skip to main content

  • Low-Risk TAVR Highly Anticipated for 2019

    • Posted: 12/29/2018
    • Author:

      Nicole Lou, Contributing Writer, MedPage Today, 

    • 2018News Articles

    Two pivotal trials will unveil results for patients under 3% surgical risk

    Transcatheter aortic valve replacement (TAVR) expansion into a low-risk population is on the table in 2019, as two pivotal trials and regulatory review for this indication are widely anticipated.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details